Mr. Louis Shenkman M.D., graduated from York University Medical School of Medicine, was a Clinical Associate at the NIH and Attending Physician at Bellevue Hospital and University Hospital, Department of Medicine, New York University.
He was chairman of medicine, Meir Hospital, Kfar Saba, and dean of the New York State/American Program of the Sackler School of Medicine, Tel Aviv University. He has conducted research in endocrinology and metabolism, authored over 130 peer-reviewed articles and served as coordinator of several FP7 European Union-funded projects, the latest, A novel nano-technological platform for pancreatic cancer diagnosis and therapy
Prof. Shenkman is the medical director of several medical high-tech companies in Israel and he serves as the medical director of BioGenCell’s clinical study.